Profile data is unavailable for this security.
About the company
Thyrocare Technologies Limited is an India-based company, which operates as a healthcare services provider. It conducts an array of medical diagnostic tests and profiles of tests that are focused on early detection and management of health disorders and diseases. Its segments include diagnostic testing services, imaging services, and others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radiopharmaceuticals, selling of consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India. It is also focused on offering pathological services.
- Revenue in INR (TTM)6.23bn
- Net income in INR839.70m
- Incorporated2000
- Employees1.69k
- LocationThyrocare Technologies LtdD-37/1, Midc, Turbhe, Opp., SandozNAVI MUMBAI 400703IndiaIND
- Phone+91 2 241252525
- Fax+91 2 227682409
- Websitehttps://www.thyrocare.com/
Mergers & acquisitions
Acquired company | THYROCARE:NSI since announced | Transaction value |
---|---|---|
Think Health Diagnostics Pvt Ltd | 56.88% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Max India Ltd | 1.55bn | -891.67m | 10.61bn | 20.00 | -- | 2.38 | -- | 6.85 | -20.43 | -20.43 | 35.48 | 103.04 | 0.226 | 2.11 | 30.15 | 77,478,550.00 | -13.01 | -- | -16.74 | -- | 77.93 | 65.15 | -57.54 | -24.36 | 1.98 | -24.45 | 0.118 | -- | -12.64 | 2.82 | -442.97 | -- | -- | -- |
GPT Healthcare Ltd | -100.00bn | -100.00bn | 13.42bn | 1.89k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.18 | -- | 12.97 | -- | 77.99 | -- | 10.33 | -- | -- | -- | 0.00 | 10.85 | 18.42 | 22.46 | 26.15 | -5.19 | -- |
Shalby Ltd | 10.07bn | 547.21m | 22.59bn | 2.85k | 41.89 | 2.24 | 19.92 | 2.24 | 5.03 | 5.03 | 92.60 | 93.85 | 0.6641 | 2.36 | 6.49 | 3,529,299.00 | 3.44 | 4.82 | 4.38 | 5.53 | 43.50 | 63.92 | 5.18 | 8.20 | 0.893 | 3.56 | 0.314 | 19.18 | 16.03 | 15.10 | 24.19 | 21.57 | 8.39 | 19.14 |
Krsnaa Diagnostics Ltd | 6.81bn | 692.16m | 29.04bn | 3.70k | 43.03 | 3.45 | 19.08 | 4.26 | 20.90 | 20.90 | 205.92 | 260.38 | 0.5743 | 4.92 | 3.39 | 1,841,019.00 | 5.84 | 6.72 | 7.91 | 8.59 | 75.75 | 82.00 | 10.16 | 11.74 | 1.01 | 3.89 | 0.2045 | -- | 27.20 | 24.25 | -8.49 | -- | 14.21 | -- |
Artemis Medicare Services Ltd | 8.92bn | 559.89m | 37.10bn | 1.99k | 68.28 | -- | 37.91 | 4.16 | 3.95 | 3.95 | 63.08 | -- | -- | -- | -- | 4,481,337.00 | -- | -- | -- | -- | -- | -- | 6.27 | 4.59 | -- | 3.04 | -- | 4.19 | 19.14 | 9.96 | 27.32 | 19.12 | -- | -- |
Indraprastha Medical Corporation Ltd | 13.19bn | 1.48bn | 37.90bn | 2.98k | 25.65 | 7.23 | 19.92 | 2.87 | 16.12 | 16.12 | 143.88 | 57.21 | 1.79 | 70.81 | 18.38 | 4,430,198.00 | 20.05 | 12.74 | 27.79 | 17.04 | 57.53 | 57.32 | 11.21 | 6.73 | 2.03 | 32.69 | 0.0588 | 33.09 | 13.29 | 9.57 | 43.89 | 34.26 | 32.34 | 22.98 |
Medi Assist Healthcare Services Ltd | 6.62bn | 702.67m | 41.71bn | 3.82k | 59.93 | -- | 34.48 | 6.30 | 9.89 | 9.56 | 93.56 | -- | -- | -- | -- | 1,734,239.00 | -- | 9.27 | -- | 16.33 | -- | 99.15 | 10.97 | 13.18 | -- | 25.98 | -- | 13.71 | 25.70 | 18.05 | -8.33 | 15.93 | -2.61 | -- |
Thyrocare Technologies Ltd | 6.23bn | 839.70m | 50.12bn | 1.69k | 60.13 | 10.26 | 37.61 | 8.04 | 15.74 | 15.74 | 116.68 | 92.19 | 1.05 | 4.75 | 12.07 | 3,681,394.00 | 13.83 | 18.17 | 16.07 | 20.97 | 70.89 | 69.66 | 13.20 | 19.56 | 2.12 | -- | 0.0366 | 83.57 | 8.58 | 7.26 | 9.94 | -3.63 | 8.88 | -2.09 |
Yatharth Hospital & Trauma Cre Srvcs Ltd | 7.74bn | 1.29bn | 50.23bn | 2.19k | 37.89 | 5.39 | 29.18 | 6.49 | 15.44 | 15.44 | 92.57 | 108.59 | 0.7952 | 15.71 | 3.58 | 3,542,136.00 | 13.27 | 11.27 | 14.10 | 13.73 | 79.44 | 77.76 | 16.68 | 12.30 | 7.20 | 86.40 | 0.0882 | 0.00 | 28.88 | 45.78 | 74.06 | 95.81 | 3.69 | -- |
Healthcare Global Enterprises Ltd | 20.39bn | 570.45m | 64.20bn | 6.15k | 113.67 | 7.45 | 25.88 | 3.15 | 4.05 | 4.05 | 145.24 | 61.83 | 0.7435 | 20.91 | 5.92 | 3,316,034.00 | 2.23 | -2.26 | 3.09 | -3.05 | 53.22 | 53.78 | 3.00 | -3.50 | 0.8419 | 1.37 | 0.6324 | -- | 12.80 | 14.35 | 64.08 | -- | -0.3308 | -- |
Holder | Shares | % Held |
---|---|---|
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Oct 2024 | 3.74m | 7.06% |
ICICI Prudential Asset Management Co. Ltd.as of 31 Oct 2024 | 1.48m | 2.80% |
quant Money Managers Ltd.as of 31 Oct 2024 | 1.10m | 2.08% |
Th�l�me Partners LLPas of 30 Sep 2023 | 745.45k | 1.41% |
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 30 Sep 2024 | 322.10k | 0.61% |
Dimensional Fund Advisors LPas of 03 Oct 2024 | 223.37k | 0.42% |
SSgA Funds Management, Inc.as of 03 Oct 2024 | 150.68k | 0.29% |
JPMorgan Asset Management (UK) Ltd.as of 31 Dec 2021 | 100.39k | 0.19% |
Mellon Investments Corp.as of 03 Oct 2024 | 96.65k | 0.18% |
Fiduciary Management, Inc.as of 31 Aug 2024 | 84.14k | 0.16% |